BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15598747)

  • 1. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
    Rong R; Tang X; Gutmann DH; Ye K
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of merlin regulates its stability and tumor suppressive activity.
    Ye K
    Cell Adh Migr; 2007; 1(4):196-8. PubMed ID: 19262146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
    James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
    Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
    Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
    Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.
    Cui Y; Groth S; Troutman S; Carlstedt A; Sperka T; Riecken LB; Kissil JL; Jin H; Morrison H
    Oncogene; 2019 Sep; 38(36):6370-6381. PubMed ID: 31312020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
    Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
    Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The merlin interacting proteins reveal multiple targets for NF2 therapy.
    Scoles DR
    Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.
    Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ
    Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
    Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W
    Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings.
    Hu Y; Liu Z; Ye K
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16853-8. PubMed ID: 16263930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
    Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
    Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.
    Xiao GH; Gallagher R; Shetler J; Skele K; Altomare DA; Pestell RG; Jhanwar S; Testa JR
    Mol Cell Biol; 2005 Mar; 25(6):2384-94. PubMed ID: 15743831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
    Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
    Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
    Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
    Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
    Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
    Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merlin sumoylation is required for its tumor suppressor activity.
    Qi Q; Liu X; Brat DJ; Ye K
    Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).
    Li W; Giancotti FG
    Cell Cycle; 2010 Nov; 9(22):4433-6. PubMed ID: 21084862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin.
    Okada M; Wang Y; Jang SW; Tang X; Neri LM; Ye K
    Cancer Res; 2009 May; 69(9):4043-51. PubMed ID: 19351837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.